BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11725557)

  • 1. [Effect of probucol on the concentration of cyclosporin A in patients with nephrotic syndrome].
    Wakasugi H; Yoshimoto M; Aoki M; Osawa R; Futami T; Ono T; Muso E; Inui K
    Nihon Jinzo Gakkai Shi; 2001 Oct; 43(7):595-9. PubMed ID: 11725557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of probucol on the blood concentration of cyclosporin A in patients with nephrotic syndrome: a case study with a microemulsion formulation (Neoral)].
    Wakasugi H; Yoshimoto M; Ono T; Muso E; Inui K
    Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):792-7. PubMed ID: 12607968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol for treatment of hyperlipidemia in persistent childhood nephrotic syndrome. Report of a prospective uncontrolled multicenter study.
    Querfeld U; Kohl B; Fiehn W; Minor T; Michalk D; Schärer K; Müller-Wiefel DE
    Pediatr Nephrol; 1999 Jan; 13(1):7-12. PubMed ID: 10100282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?
    Filler G
    Nephrol Dial Transplant; 2005 Jun; 20(6):1032-4. PubMed ID: 15814537
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol on hyperlipidemia in patients with nephrotic syndrome.
    Iida H; Izumino K; Asaka M; Fujita M; Nishino A; Sasayama S
    Nephron; 1987; 47(4):280-3. PubMed ID: 3696330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy.
    Kuroyanagi Y; Gotoh Y; Kasahara K; Nagano C; Fujita N; Yamakawa S; Yamamoto M; Takeda A; Uemura O
    Clin Exp Nephrol; 2018 Apr; 22(2):413-419. PubMed ID: 28699031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
    Ariceta Iraola G; Rodríguez Soriano J; Vallo Boado A; Quintela Pérez MJ; Oliveros Pérez R
    An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y; Hosoya M; Kobayashi S; Ohara S; Onishi N; Takahashi A; Isome M; Suzuki H
    Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cyclosporin A on the diurnal variation of blood pressure in patients with nephrotic syndrome].
    Takakuwa H; Yokoyama H; Yamamoto Y; Takasawa K; Ise T; Kobayashi K; Kawabata M; Takabatake T; Ohta H
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):400-7. PubMed ID: 9198362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporine in the treatment of primary focal-segmental glomerulosclerosis].
    Pavlović S; Djukanović Lj; Sindjić M; Stojković D; Banković-Calić N; Velimirović D
    Srp Arh Celok Lek; 1996; 124 Suppl 1():51-3. PubMed ID: 9102929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.